Showing results (51-60 of 62) with videos related to
Sort By:
Pageof 7
BMJ (Clinical Research Ed.)|June 10, 2021
Postoperative low molecular weight heparin bridging treatment for patients at high risk of arterial thromboembolism (PERIOP2): double blind randomised controlled trialMichael J Kovacs, Philip S Wells, David R Anderson, et al.Thrombosis Research|October 6, 2023
Serial D-dimers after anticoagulant cessation in unprovoked venous thromboembolism: Data from the REVERSE cohort studyYan Xu, Faizan Khan, Michael J Kovacs, et al.Transfusion Medicine Reviews|April 25, 2025
Identifying Modifiers of CAR T-Cell Therapeutic Efficacy and Safety: A Systematic Review and Individual Patient Data Meta-AnalysisManoj M Lalu, Samuel Igweokpala, Natasha Kekre, et al.Journal of Thrombosis and Haemostasis : JTH|March 16, 2021
Long-term risk of recurrent venous thromboembolism after a first contraceptive-related event: Data from REVERSE cohort studyDavid Aziz, Leslie Skeith, Marc A Rodger, et al.JAMA|November 27, 2012
Daily sedation interruption in mechanically ventilated critically ill patients cared for with a sedation protocol: a randomized controlled trialSangeeta Mehta, Lisa Burry, Deborah Cook, et al.BMJ Open|September 24, 2017
Long-term risk of recurrence after discontinuing anticoagulants for a first unprovoked venous thromboembolism: protocol for a systematic review and meta-analysisFaizan Khan, Alvi Rahman, Marc Carrier, et al.Cancer Discovery|August 18, 2018
Targeting the MTF2-MDM2 Axis Sensitizes Refractory Acute Myeloid Leukemia to ChemotherapyHarinad B Maganti, Hani Jrade, Christopher Cafariello, et al.BMJ (Clinical Research Ed.)|September 14, 2018
Effect of high dose folic acid supplementation in pregnancy on pre-eclampsia (FACT): double blind, phase III, randomised controlled, international, multicentre trialShi Wu Wen, Ruth Rennicks White, Natalie Rybak, et al.The New England Journal of Medicine|April 9, 2015
Age of transfused blood in critically ill adultsJacques Lacroix, Paul C Hébert, Dean A Fergusson, et al.BMJ (Clinical Research Ed.)|July 26, 2019
Long term risk of symptomatic recurrent venous thromboembolism after discontinuation of anticoagulant treatment for first unprovoked venous thromboembolism event: systematic review and meta-analysisFaizan Khan, Alvi Rahman, Marc Carrier, et al.Pageof 7